---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-086352"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:54:57.348141+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Disc Medicine stockholders elect three Class II directors, approve say-on-pay, ratify EY auditor

## Summary
- Elected Georges Gemayel, Mark Chin, and Liam Ratcliffe as Class II directors for three-year term ending 2028.
- Non-binding advisory vote approved executive compensation: 30,801,342 for, 235,453 against, 6,286 abstain.
- Stockholders recommended say-on-pay vote every year; board adopted annual frequency until at least 2031.
- Ratified Ernst & Young as independent registered public accounting firm for FY2025: 32,117,099 for, 2,370 against, 488 withheld.
- All proposals passed with majority support; broker non-votes ranged from 1,076,876 on director elections to none on auditor ratification.

## SEC filing metadata
- accession: 0000950170-25-086352
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000095017025086352/0000950170-25-086352-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000095017025086352/iron-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-086352
- JSON: https://secwatch.observer/filing/0000950170-25-086352.json
- Plain text: https://secwatch.observer/filing/0000950170-25-086352.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.